The future of treating metabolic dysfunction–associated steatohepatitis (MASH) looks brighter than ever, says Naim Alkhouri, MD, as data emerges on newly developed interventions.

People are not born allergic to things, but they can be born with a genetic tendency to become allergic to things to which ...